Rybelsus Tablets 7mg, from Novo Nordisk Pharma, contain Semaglutide (genetical recombination) and are prescribed for adults with type 2 diabetes. It works by increasing insulin release, reducing liver glucose production, and slowing digestion to improve blood sugar control. YJ code: 2499014F2028, Standard: 7mg 1 tablet.
Rybelsus Tablets 7mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →